Prion diseases, also known as transmissible spongiform encephalopathies, are infectious fatal neurodegenerative diseases of humans and animals. A major feature of prion diseases is the refolding and aggregation of a normal host protein, prion protein (PrP) into a disease-associated form which may contribute to brain damage. In uninfected individuals normal PrP is anchored to the outer cell membrane by a sugar-phosphate-lipid linker molecule, known as GPI. In FY10 we showed that prion infection of mice expressing PrP lacking the GPI anchor resulted in a new type of fatal highly transmissible amyloid neurodegenerative disease. This disease displayed mechanisms of damage to brain cells and brain blood vessels found in Alzheimers disease and in familial amyloid brain diseases. In contrast, the typical sponge-like brain damage seen in prion diseases was not observed. These results suggested that presence or absence of PrP membrane anchoring could influence the type of neurodegeneration seen after prion infection. We are currently studying the role of PrP anchoring on susceptibility to prion infection by different routes of inoculation, including sciatic nerve, tongue, eye, intravenous and intraperitoneal. The preliminary results suggest that lack of PrP anchoring alters neuroinvasion by many of these routes. In other experiments in FY10 we continued to study the roles of cytokine and chemkine expression in brain on prion brain diseases. We are currently determining the kinetics of cytokine expression relative to brain damage in mice with either anchored PrP or anchorless PrP, in order to determine whether the cytokines precede or follow damage. This result should help determinee the role of cytokines in the disease process. We are also investigating the role of expression of normal prion protein on function of glutamate transporters in astrocytes in vitro. Primary undifferentiated astrocytes are being compared to astrocytes differentiated in vitro with either cAMP or neuron-conditioned medium, or co-cultivated with live neurons.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2010
Total Cost
$1,581,907
Indirect Cost
City
State
Country
Zip Code
Race, Brent; Williams, Katie; Hughson, Andrew G et al. (2018) Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein. Acta Neuropathol Commun 6:13
Carroll, James A; Race, Brent; Williams, Katie et al. (2018) Microglia Are Critical in Host Defense Against Prion Disease. J Virol :
Carroll, James A; Striebel, James F; Rangel, Alejandra et al. (2016) Prion Strain Differences in Accumulation of PrPSc on Neurons and Glia Are Associated with Similar Expression Profiles of Neuroinflammatory Genes: Comparison of Three Prion Strains. PLoS Pathog 12:e1005551
Race, Brent; Phillips, Katie; Kraus, Allison et al. (2016) Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease. Prion 10:319-30
Striebel, James F; Race, Brent; Carroll, James A et al. (2016) Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice. J Gen Virol 97:1481-7
Race, Brent; Phillips, Katie; Meade-White, Kimberly et al. (2015) Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein. J Virol 89:6022-32
Carroll, James A; Striebel, James F; Race, Brent et al. (2015) Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction. J Virol 89:2388-404
Chesebro, Bruce; Striebel, James; Rangel, Alejandra et al. (2015) Early Generation of New PrPSc on Blood Vessels after Brain Microinjection of Scrapie in Mice. MBio 6:e01419-15
Evans, Leonard H; Boi, Stefano; Malik, Frank et al. (2014) Analysis of two monoclonal antibodies reactive with envelope proteins of murine retroviruses: one pan specific antibody and one specific for Moloney leukemia virus. J Virol Methods 200:47-53
Moore, Roger A; Sturdevant, Dan E; Chesebro, Bruce et al. (2014) Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis. J Proteome Res 13:4620-34

Showing the most recent 10 out of 25 publications